Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 14, 2016; 22(2): 649-658
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.649
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.649
Ref. | Cases/controls, n | Matching variables | Measure of H. pylori status | Outcome | Adjusted OR (95%CI) |
Talley et al[20], 1991, United States | 80/252 | Convenience sample | IgG | Cancer | 1.17 (1.03-2.84) |
Penman et al[26], 1994, United Kingdom | 42/34 | Age, Gender | UBT | Cancer | 1.31 (0.52-3.26) |
Moss et al[25], 1995, United States | 41/41 | Age, Gender, Race | IgG | Cancer | 0.74 (0.30-1.79) |
Meucci et al[18], 1997, Italy | 94/100 | Age, Gender | IgG | Adenoma or Cancer | 1.92 (1.08-3.43) |
Thorburn[29], 1998, United States2 | 233/233 | Age, Gender, Education, Region, Date | IgG | Cancer | 1.02 (0.69-1.51) |
Breuer-Katschinski et al[14], 1999, Germany | 98/98 | Age, Gender | IgG | Polyp | 2.10 (1.12-3.92) |
Fireman et al[21], 2000, Israel | 51/51 | Convenience sample | IgG | Cancer | 2.43 (1.00-5.59) |
Hartwich et al[16], 2001, Poland | 80/160 | Age, Gender | IgG, UBT | Cancer | 3.78 (1.89-7.53) |
Shmuely et al[27], 2001, Israel | 67/92 | Convenience sample | IgG, CagA | Cancer | 1.35 (0.67-2.74) |
Siddheshwar et al[28], 2001, United Kingdom | 189/179 | Age, Gender, Social class | IgG | Cancer | 1.1 (0.7-1.8) |
Polyp | 1.3 (0.7-2.5) | ||||
Limburg et al[23], 2002, Finland2 | 118/236 | Age, Gender1, Study center, Date of serum collection | CagA, whole cell assay | Cancer | 0.91 (0.53-1.55) |
Fujimori et al[15], 2005, Japan | 481/188 | Age | UBT, urease test, histological diagnosis | Adenoma | 1.60 (1.18-2.02) |
Cancer | 1.80 (1.28-2.32) | ||||
Inoue et al[17], 2011, Japan3 | 239/239 | Age | IgG | Adenoma | 2.52 (1.57-4.05) |
Zhang et al[30], 2012, Germany3 | 1712/1669 | Age, Gender, Colorectal risk factors, Former colorectal endoscopy | IgG, CagA | Cancer | 1.22 (1.02-1.45) |
Ref. | Included studies, n | Outcome | Summary OR (95%CI) | Conclusion |
Zumkeller et al[45], 2006, Germany | 111 | Cancer | 1.4 (1.1-1.8) | Possible small increase in the risk of CRC |
Zhao et al[44], 2008, China | 131 (9 using IgG to detect infection status) | Cancer | 1.49 (1.17-1.91) | Possible increase in risk of CRC |
1.56 (1.14-2.14) evaluating IgG as the only test indicator) | ||||
Hong et al[34], 2012, South Korea | 10 | Adenoma | 1.58 (1.32-1.88) | Modest increase in the risk of colorectal adenoma |
Wu et al[43], 2013, China | 27 | Adenoma | 1.66 (1.39-1.97) | Positive association between H. pylori and colorectal neoplasia |
Cancer | 1.39 (1.18-1.64) | |||
Rokkas et al[42], 2013, Greece | 28 | Polyps | 1.50 (1.26-1.79) | Modest statistically significant relationship of H. pylori with both cancer and polyps |
Cancer | 1.30 (1.07-1.59) | |||
Chen et al[46], 2013, China | 22 | Cancer | 1.49 (1.30-1.72) | H. pylori increases the risk of CRC |
Guo et al[41], 2014, China | 92 | Hyperplastic polyp | 0.72 (0.44-1.18) | No statistical association between H. pylori and colorectal neoplasm was found, but H. pylori may increase the risk of adenoma |
Adenoma | 1.83 (1.35-2.51) | |||
Cancer | 1.08 (0.89-1.68) |
- Citation: Papastergiou V, Karatapanis S, Georgopoulos SD. Helicobacter pylori and colorectal neoplasia: Is there a causal link? World J Gastroenterol 2016; 22(2): 649-658
- URL: https://www.wjgnet.com/1007-9327/full/v22/i2/649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i2.649